NR4A1 and breast cancer: More than one-third of patients with newly diagnosed breast cancer are aged 70 years or older.1 Most of these patients receive a diagnosis at an early stage, and their cancers have the favorable characteristic of expressing estrogen and progesterone receptors (ie, they are hormone receptor [HR] positive).